Efficacy of Nicotinamide for the Treatment of Alzheimer's Disease.

Trial Profile

Efficacy of Nicotinamide for the Treatment of Alzheimer's Disease.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 02 Feb 2017

At a glance

  • Drugs Nicotinamide (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 11 Dec 2013 Planned end date changed from 1 Jul 2012 to 1 Jul 2014 as reported by ClinicalTrials.gov.
    • 28 Jun 2012 Planned end date changed from 1 Apr 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top